Your browser doesn't support javascript.
loading
Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice.
Na, Manli; Wang, Wanzhong; Fei, Ying; Josefsson, Elisabet; Ali, Abukar; Jin, Tao.
Afiliação
  • Na M; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at Gothenburg University, S-41346 Göteborg, Sweden.
  • Wang W; Department of Medical Biosciences, Umeå University, Umeå, Sweden.
  • Fei Y; Department of Microbiology and Immunology, The Affiliated Hospital of GuiZhou Medical University, Guiyang, P.R. China.
  • Josefsson E; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at Gothenburg University, S-41346 Göteborg, Sweden.
  • Ali A; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at Gothenburg University, S-41346 Göteborg, Sweden.
  • Jin T; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at Gothenburg University, S-41346 Göteborg, Sweden.
PLoS One ; 12(3): e0173492, 2017.
Article em En | MEDLINE | ID: mdl-28264025
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Fator de Necrose Tumoral alfa / Dermatite / Antígeno CTLA-4 / Abatacepte / Etanercepte Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Fator de Necrose Tumoral alfa / Dermatite / Antígeno CTLA-4 / Abatacepte / Etanercepte Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia